MENU
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BioMarin Pharmaceutical (BMRN) Ownership - Who owns BioMarin Pharmaceutical?
BioMarin's focus is on rare-disease therapies... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.47B
P/E Ratio
31.95
Total Cash
930.44M
Projected Growth
0.48
Total Debt
602.69M
Revenue
2.75B
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash/Share
4.88
Total Debt/Equity
45.30
Revenue/Share
14.51 USD as % of share price
Fundamentals
BMRN
Capitalization
13.5B
P/E Ratio
31.95
Risk (Beta)
0.37
Dividend Yield
N/A
Total Cash
930M
Total Cash/Share
4.88
Total Debt
603M
Total Debt/Equity
45.30
Projected Growth (PEG Ratio)
0.48
Revenue/Share (as % of the share price)
14.51%
Revenue
2.75B
ROE
N/A
Book Value
5.41B
P/B Ratio
2.38
Cash Flow
N/A
Earnings
1.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
191K
Current Ratio
4.27
Current Revenue Per Employee
219270.80
Dividends Per Share - Security
N/A
EBITDA
507M
Float
N/A
Float - Current
N/A
Gross Income Margin
74.73
Revenue To Assets
4.74
Shares Held By Institutions
27.8B
Shares Outstanding - Current
191M
Total Liabilities
1.44B
Total Volume MTD
N/A
Value
-1
Gain YTD
7.409
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of innovative pharmaceuticals for serious diseases & medical conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3401
Web
https://www.biomarin.com